HHS Secretary Robert F. Kennedy Jr. announced Tuesday that preliminary observations from a highly funded group of technology executives suggest artificial intelligence may be drastically better informed than human physicians, though experts caution the findings have not yet been evaluated outside the VIP donor lounge.
Speaking alongside Vice President JD Vance at the MAHA Summit—a gathering closely associated with severe, acute corporate lobbying—Kennedy highlighted a strong link between the algorithms' vast medical knowledge and the size of the checks their parent companies clear with the federal government. However, independent researchers stress that the difference between correlation and causation remains unclear in this specific sample of keynote speakers, noting that the administration's symptom improvement only occurred after substantial financial infusions.
While the initial phase-one lobbying efforts demonstrate robust efficacy, we must warn against adopting these algorithms as a first-line diagnostic until longitudinal trials can confirm whether the program actually knows medicine, or simply knows how to flatter a cabinet secretary.
The data, largely provided by the tech conglomerates sponsoring the conference buffet, indicated a 94 percent success rate in the models telling the administration exactly what it wanted to hear regarding deregulation. A CDC spokesperson noted that while standard validation for new diagnostic tools typically involves double-blind clinical trials, federal regulators have tentatively accepted three catered lunches with JD Vance as an alternative approval pathway, citing the urgent need to accelerate innovation in the government procurement sector.
Until a broader consensus is reached, federal health officials suggest patients should continue consulting traditional, human doctors, at least until those practitioners can secure sufficient venture capital funding to establish their own statistical significance.